Evidence map›Paper›PMID 33731860›Full record

ArticleOncogene2021

The age of adult pilocytic astrocytoma cells.

Natalia Voronina, Christian Aichmüller, Thorsten Kolb, Andrey Korshunov, Marina Ryzhova, Jill Barnholtz-Sloan, Gino Cioffi, Martin Sill, Andreas von Deimling, Stefan M Pfister and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Oncogene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Pilocytic astrocytoma: A rare case report.Radiology case reports · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Natalia Voronina *Group Genome Instability in Tumors, DKFZ, Heidelberg, Germany.
Christian Aichmüller *Division of Molecular Genetics, DKFZ, DKFZ-Heidelberg Center for Personalized Oncology (HIPO) and German Cancer Consortium (DKTK), Heidelberg, Germany.
Thorsten Kolb *Group Genome Instability in Tumors, DKFZ, Heidelberg, Germany.
Andrey KorshunovDepartment of Neuropathology, Heidelberg University Hospital, and CCU Neuropathology, DKFZ, Heidelberg, Germany.
Marina RyzhovaNN Burdenko Neurosurgical Institute, Moscow, Russia.
Jill Barnholtz-SloanDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-6190-9304
Gino CioffiDepartment of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Martin SillHopp Children's Cancer Center Heidelberg (KiTZ); Division of Pediatric Neurooncology, DKFZ; German Cancer Consortium (DKTK), DKFZ; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Andreas von DeimlingDepartment of Neuropathology, Heidelberg University Hospital, and CCU Neuropathology, DKFZ, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-5863-540X
Stefan M PfisterHopp Children's Cancer Center Heidelberg (KiTZ); Division of Pediatric Neurooncology, DKFZ; German Cancer Consortium (DKTK), DKFZ; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Jan GronychHopp Children's Cancer Center Heidelberg (KiTZ), Division of Pediatric Neurooncology, DKFZ; German Cancer Consortium (DKTK), DKFZ, Heidelberg, Germany.
David T W JonesHopp Children's Cancer Center Heidelberg (KiTZ), Pediatric Glioma Research Group, Heidelberg, Germany.
Jonas FrisénDepartment of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Marc ZapatkaDivision of Molecular Genetics, DKFZ, DKFZ-Heidelberg Center for Personalized Oncology (HIPO) and German Cancer Consortium (DKTK), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-8287-5967
Aurélie ErnstGroup Genome Instability in Tumors, DKFZ, Heidelberg, Germany. a.ernst@dkfz.de.ORCID http://orcid.org/0000-0002-8082-3677
Heidelberg University · DEGerman Cancer Research Center · DECentral Brain Tumor Registry of the United States · USBurdenko Neurosurgery Institute · RUHopp Children's Cancer Center Heidelberg · DEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult pilocytic astrocytomas (PAs) have been regarded as indistinguishable from pediatric PAs in terms of genome-wide expression and methylation patterns. It has been unclear whether adult PAs arise early in life and remain asymptomatic until adulthood, or whether they develop during adulthood. We sought to determine the age and origin of adult human PAs using two types of "marks" in the genomic DNA. First, we analyzed the DNA methylation patterns of adult and pediatric PAs to distinguish between PAs of different anatomic locations (n = 257 PA and control brain tissues). Second, we measured the concentration of nuclear bomb test-derived

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsAstrocytomaChildChild, PreschoolHumansIncidenceInfantInfant, NewbornMiddle AgedYoung Adult

Identifiers

PMID33731860
PMCPMC8062266
OpenAlexW3136267649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.